Recruiting

RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(14 sites)

United States

Banner MD Anderson Cancer Center, Gilbert, Arizona

The University of Arizona Cancer Center, Tucson, Arizona

Miami Cancer Institute, Miami, Florida

Northwestern University Feinberg School of Medicine, Chicago, Illinois

Parkview Cancer Institute, Fort Wayne, Indiana

Willis Knighton Cancer Center, Shreveport, Louisiana

Sandra and Malcolm Berman Cancer Institute, Baltimore, Maryland

University of Michigan, Ann Arbor, Michigan

Renown Regional Medical Center, Reno, Nevada

East Carolina University School of Medicine, Greenville, North Carolina

The Ohio State University James Cancer Hospital & Solove Research Institute, Columbus, Ohio

Ballad Health, Johnson City, Tennessee

University of Texas Southwestern Medical Center, Dallas, Texas

University of Virginia, Charlottesville, Virginia